J1456 HCPCS code: Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
J1456 is the HCPCS Level II code for injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg. In 2024 Medicare paid an average of $1.27 per service for J1456 across 120,909 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 150 per day on outpatient hospital claims. Medicare volume fell 30% from 2023 to 2024 (172,816 to 120,909 services). In 2024, about 95 clinicians billed Medicare for J1456 for 276 beneficiaries; Arizona, California, Pennsylvania accounted for 73% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-01-01 |
| Last action effective | 2024-01-01 |
Who bills J1456 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 95 |
| Medicare beneficiaries | 276 |
| States with claims | 5 |
| Share of services in top 3 states (Arizona, California, Pennsylvania) | 73% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1456, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 172,816 | 560 | $0.56 | $0.45 |
| 2024 | 120,909 | 276 | $1.34 | $1.27 |
States with the most J1456 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Arizona | 28,350 | $0.45 |
| California | 25,203 | $1.24 |
| Pennsylvania | 20,706 | $1.89 |
| New York | 20,400 | $1.89 |
| Iowa | 7,350 | $1.41 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 150 | Prescribing Information |
| practitioner claims | 150 | Prescribing Information |
What changed for J1456
- 2023-01-01: J1456 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1456?
J1456 is the HCPCS Level II code for injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg. Short descriptor: "Inj, fosaprepitant (teva)".
How much does Medicare pay for J1456?
In 2024, the average Medicare payment was $1.27 per service (average allowed $1.34).
Does Medicare cover J1456?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1456 can be billed per day?
150 on outpatient hospital claims; 150 on practitioner claims (NCCI medically unlikely edits).
Related J14 codes
- J1410 — Injection, estrogen conjugated, per 25 mg
- J1411 — Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
- J1412 — Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
- J1413 — Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
- J1414 — Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
- J1426 — Injection, casimersen, 10 mg
- J1427 — Injection, viltolarsen, 10 mg
- J1428 — Injection, eteplirsen, 10 mg
- J1429 — Injection, golodirsen, 10 mg
- J1430 — Injection, ethanolamine oleate, 100 mg
- J1434 — Injection, fosaprepitant (focinvez), 1 mg
- J1435 — Injection, estrone, per 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1456
- Watch J1456 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1456
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.